scispace - formally typeset
V

Venkatesh Krishnan

Researcher at Eli Lilly and Company

Publications -  43
Citations -  2869

Venkatesh Krishnan is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Estrogen receptor & Agonist. The author has an hindex of 22, co-authored 43 publications receiving 2155 citations.

Papers
More filters
Journal ArticleDOI

Wnt10b Increases Postnatal Bone Formation by Enhancing Osteoblast Differentiation

TL;DR: In this article, Wnt signaling regulates many aspects of development including postnatal accrual of bone, including bone formation and bone formation rate, by stimulating osteoblastogenesis.
Journal ArticleDOI

Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.

TL;DR: In a case series of patients with bilateral COVID‐19 pneumonia, baricitinib treatment was associated with clinical and radiologic recovery, a rapid decline in SARS‐CoV‐2 viral load, inflammatory markers, and IL‐6 levels, and these data support further evaluation of the anti‐cytokine and anti‐viral activity of baricit inib and support its assessment in randomized trials in hospitalized CO VID‐19 patients.
Journal ArticleDOI

Osteoblast Apoptosis and Bone Turnover

TL;DR: The paradoxical effects of parathyroid hormone (PTH) on osteoblast apoptosis in vivo are considered in the perspective of a recent hypothesis speculating that this may be a key mechanism to explain the anabolic effects of the hormone.